Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults

[1]  François Mach,et al.  Inflammation and Atherosclerosis , 2004, Herz.

[2]  Alessandro Pontillo,et al.  Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.

[3]  N. Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[4]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[5]  J. Manson,et al.  Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. , 2002, JAMA.

[6]  C. Kluft,et al.  Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment. , 2002, Vascular pharmacology.

[7]  J. Jespersen,et al.  Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations. , 2002, American journal of obstetrics and gynecology.

[8]  R. Marfella,et al.  Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year , 2002, Circulation.

[9]  S. Haffner,et al.  The relation of body fat mass and distribution to markers of chronic inflammation , 2001, International Journal of Obesity.

[10]  Paul M. Ridker,et al.  High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. , 2001, Circulation.

[11]  J. Després,et al.  Treatment of obesity: need to focus on high risk abdominally obese patients , 2001, BMJ : British Medical Journal.

[12]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[13]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[14]  A. Döring,et al.  C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. , 1999, Circulation.

[15]  J. Després,et al.  The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men , 1996, Diabetes Care.

[16]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[17]  R N Pierson,et al.  How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? , 1996, American journal of epidemiology.

[18]  B. Morgenstern,et al.  Human blood pressure determination by sphygmomanometry. , 1993, Circulation.

[19]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[20]  J. Salonen,et al.  Body weight and risk of myocardial infarction and death in the adult population of eastern Finland. , 1987, British medical journal.

[21]  P. Björntorp,et al.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.

[22]  J. Connell,et al.  C-reactive protein in pregnancy and contraception. , 1971, American journal of obstetrics and gynecology.

[23]  W. Ledger,et al.  Antinuclear antibodies, rheumatoid factor and C-reactive protein in serum of normal women using oral contraceptives. , 1971, Arthritis and rheumatism.

[24]  Warwick B. Elley,et al.  The Elley-Irving Socio-economic Index: 2001 Census revision. , 2003 .

[25]  R. Marfella,et al.  Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese Women , 2003 .

[26]  I. Godsland,et al.  Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms. , 2000, Drugs.

[27]  R. Tracy,et al.  The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. , 2000, The Journal of clinical endocrinology and metabolism.

[28]  M. Moore.  Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. , 1998, Journal of insurance medicine.

[29]  Phil A. Silva,et al.  From child to adult : the Dunedin multidisciplinary health and development study , 1996 .

[30]  P. Lichtlen,et al.  Coronary atherosclerosis and myocardial infarction in young women--role of oral contraceptives. , 1983, European heart journal.

[31]  M. Feinleib,et al.  Obesity as an independent risk factor for cardiovascular disease: a 26 year follow up of participant , 1983 .

[32]  F A Mathewson,et al.  Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: the Manitoba Study. , 1977, The American journal of cardiology.